Thermogenesis (adaptive increases in heat production) can develop in r
esponse to low environmental temperature, alterations in the amount or
composition of the diet, and pathogenic stimuli, such as infection, i
njury, and inflammation. Thermogenic responses to each of these stimul
i appear to be mediated by activation of the sympathetic nervous syste
m and, at least in experimental animals, by heat production in brown f
at. Thermogenesis is under the direct control by the central nervous s
ystem (CNS), particularly by specific regions of the hypothalamus. Ser
otonergic pathways have been directly implicated in the central contro
l of most forms of thermogenesis, and indirect evidence suggests invol
vement of adrenergic and cholinergic mechanisms. Numerous peptides hav
e been shown to induce increases on metabolic rate when injected into
the brains of experimental animals; of these, corticotrophin-releasing
factor (CRF) has been the most extensively studied. CRF appears to me
diate thermogenic responses to serotonergic agonists, injury, and cyto
kines, and may be involved in impaired thermogenic responses in certai
n genetically obese rodents. Cytokines, particularly interleukin-1 (IL
-1) and IL-6, act as endogenous pyrogens in the brain and stimulate th
ermogenesis via synthesis of prostaglandins and CRF. Peptides such as
lipocortin-1, arginine vasopressin, and alphaMSH potently inhibit cent
ral effects of cytokines. Pharmacological modification of thermogenesi
s may be clinically beneficial in treating conditions such as obesity,
cachexia, and fever.